ATP1A1 and Ewing sarcoma: To explore the potential of ATP1A1, BCL11B, GLG1, and CD99 as prognostic biomarkers, we analyzed the association of their expression levels with outcome in a large cohort of Ewing sarcoma patients (n = 166).